GlassScriptPhysician profile
Reva Jain
NPI 1770100646
$2,420.06
in general payments reported to CMS, 2019-2025
15 companies · $48.01 in 2025
The $48.01 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,900 · 2023: $428 · 2024: $43.83 · 2025: $48.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,676.32 | 2022-2023 | Senza |
| Abbvie INC. | $230.75 | 2023-2024 | |
| Spr Therapeutics, INC | $95.97 | 2022-2025 | Sprint Pns System |
| Nalu Medical, INC. | $90.07 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $58.98 | 2022 | |
| Ibsa Pharma INC. | $50.23 | 2022-2023 | Tirosint, Licart |
| Relievant Medsystems, INC. | $42.99 | 2022-2023 | Intracept |
| Medtronic, INC. | $36.38 | 2023 | Intellis Adaptivestim |
| Sanofi-Aventis U.S. LLC | $26.45 | 2022 | |
| Collegium Pharmaceutical, INC. | $21.11 | 2022 | |
| Grt US Holding, INC. | $20.88 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.49 | 2023 | Relistor |
| Pfizer INC. | $18.26 | 2023 | |
| Scilex Pharmaceuticals INC. | $18.25 | 2022 | |
| Si-Bone, INC. | $13.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reva Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.